arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Vera Therapeutics, Inc.

VERA

$30.17 ▼ -1.80 (-5.63%) at close

27 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Neutral

auto_awesome

Analytical Summary

Vera Therapeutics, Inc. demonstrates solid fundamentals with strength in Debt to Equity. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $2.2B

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -18.4% ↘

FCF / Share $-1.40 ↗

Trailing P/E —

Price / Book 5.3x

FCF Yield —

Debt / Equity 0.18

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-121.03M

↓ -134.1% —

FCF / Share Free cash flow per share

$-1.40

↑ +6.4% —

Long-Term Debt Long-term obligations

$75.23M

— +0.3% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	-26.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-108.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-93.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-48.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-93.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-44.6% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-24.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-88.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-34.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	51.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	50.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	—	-22.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-152.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-66.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-134.1% Weak ↓ Weak Declining Year-over-year change in net income	-134.1% Weak ↓ Weak Declining Year-over-year change in net income	-109.8% Weak ↓ Weak Declining Year-over-year change in net income	-82.1% Weak ↓ Weak Declining Year-over-year change in net income	-82.1% Weak ↓ Weak Declining Year-over-year change in net income	-82.1% Weak ↓ Weak Declining Year-over-year change in net income	-69.3% Weak ↓ Weak Declining Year-over-year change in net income	5.6% Fair ↓ Fair Declining Year-over-year change in net income	5.6% Fair ↑ Fair Improving Year-over-year change in net income	5.6% Fair ↑ Fair Improving Year-over-year change in net income	20.9% Good ↑ Good Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-92.6% Weak ↑ Weak Improving Year-over-year change in net income	-262.4% Weak ↓ Weak Declining Year-over-year change in net income	-262.4% Weak ↓ Weak Declining Year-over-year change in net income	-262.4% Weak ↓ Weak Declining Year-over-year change in net income	60.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-90.5% Weak → Weak Stable Year-over-year change in net income	-90.5% Weak Weak Year-over-year change in net income	-90.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-73.8% Weak Weak Year-over-year change in free cash flow	—	—	—	-29.2% Weak Weak Year-over-year change in free cash flow	—	—	—	4.9% Caution Caution Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.20x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	—	1.06x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.16x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.63x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-18.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-14.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-7.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-21.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-18.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	37.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	6.8% Caution ↑ Caution Improving Return earned on debt + equity capital invested Optimal: > 10%	5.9% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	5.0% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-21.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	—	-12.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-11.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-19.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-78.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-29.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-298%)	-24.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-15.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-200%)	-13.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-186%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-7.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-8.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-158%)	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-25.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-268%)	-24.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-21.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-243%)	-19.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-227%)	-42.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-381%)	-16.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	-14.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-194%)	-12.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	-24.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-5.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-5.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-134%)	5.1% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-66%)	48.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+220%)	5.3% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-65%)	5.8% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-61%)	6.4% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-58%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	0.18x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	0.15x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-75%)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-79%)	0.19x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-69%)	0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	0.10x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-84%)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-85%)	0.17x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-71%)	0.15x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.14x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-76%)	—	0.20x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-66%)	0.18x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-70%)	0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	0.32x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-46%)	0.05x Excellent → Excellent Stable Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	0.04x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-93%)	0.04x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—
Interest Coverage (x)	-68.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-76.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-54.90x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-47.53x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-36.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-29.43x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-19.53x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.32x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-31.69x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-24.04x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-35.76x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-56.06x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-171.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-117.63x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-144.25x Weak Weak Operating income divided by interest expense Optimal: > 5x	-829.25x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-2837.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-63.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-50.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	-102.96x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$26.35M	$-39.32M	$-279.89M	$16.88M	$25.34M	$-4.18M	$-41.96M	$23.21M	$25.18M	$-19.04M	—	$-2.40M	$-8.93M	$-112.50M	$-18.65M	$-25.51M	$-45.48M	$-106.57M	$-74.75M	—	—	$-49.51M	$-53.65M	—	—	—	—
Debt / EBITDA (x)	-0.67x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.60x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.89x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.93x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.89x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.04x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.01x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.35x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.61x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-1.15x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.80x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.74x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.20x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.30x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	0.00x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Basic EPS, GAAP (USD)	$-1.52	$-1.69	$-1.39	$-1.26	$-1.20	$-0.81	$-0.72	$-0.85	$-0.62	$-0.56	$-0.58	$-0.45	$-0.46	$-0.80	$-1.19	$-0.91	$-0.55	—	$-0.97	$-0.36	$-0.33	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.40	$-1.49	—	$-0.97	—	$-0.86	—	—	—	$-0.66	—	—	—	$-0.70	—	—	—	—	—	$-0.26	$-0.73	—	—	—	—	—	—
Book Value per Share (USD)	$5.68	$6.99	—	$6.25	$7.34	$8.40	—	$5.27	$5.99	$6.94	—	$2.79	$3.17	$4.19	—	$3.88	$4.49	—	—	$4.02	$8.78	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$5.68	$6.99	—	$6.25	$7.34	$8.40	—	$5.27	$5.99	$6.94	—	$2.79	$3.17	$4.19	—	$3.88	$4.49	—	—	$4.02	$8.78	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	71.84M	71.48M	—	63.85M	63.79M	63.67M	—	54.90M	54.73M	50.97M	—	44.36M	44.27M	37.67M	—	27.22M	27.08M	—	—	21.27M	10.50M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$479.17M	$570.65M	$675.43M	$469.43M	$537.80M	$584.18M	$625.85M	$337.67M	$376.33M	$401.83M	—	$147.00M	$163.78M	$180.92M	$100.10M	$109.06M	$125.06M	$137.77M	$74.85M	—	—	$47.78M	$51.85M	—	—	—	—
LT Debt (USD)	$75.23M	$75.03M	$74.84M	$74.65M	$74.46M	$50.91M	$50.69M	$50.47M	$50.26M	$50.07M	—	$25.04M	$24.96M	$24.89M	$24.81M	$4.97M	$4.95M	$4.94M	$4.92M	—	—	—	$0.00	—	—	—	—
Total Equity (USD)	$407.76M	$499.70M	$604.52M	$398.88M	$468.28M	$535.00M	$577.15M	$289.06M	$327.87M	$353.54M	$101.69M	$123.71M	$140.52M	$157.71M	$76.91M	$105.72M	$121.50M	$134.43M	$69.59M	$85.48M	$92.16M	$-93.32M	$-89.35M	$-46.88M	$-42.47M	$-38.95M	$-36.55M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Depreciation Expense (USD)	$132.00K	$140.00K	$135.00K	$129.00K	—	$85.00K	$55.00K	—	—	—	$4.00K	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-121.03M	$-121.03M	$-91.10M	$-51.69M	$-51.69M	$-51.69M	$-43.42M	$-28.38M	$-28.38M	$-28.38M	$-25.66M	$-30.07M	$-30.07M	$-30.07M	$-32.44M	$-17.09M	$-17.09M	$-17.09M	$-16.85M	$-4.71M	$-4.71M	$-4.71M	$-42.88M	$-2.47M	$-2.47M	$-2.47M	—
Operating Cash Flow (USD)	$-100.25M	$-106.50M	$-69.99M	$-61.91M	—	$-54.41M	$-39.18M	—	—	$-33.83M	$-25.14M	—	—	$-26.29M	$-21.16M	—	—	$-8.98M	$-6.44M	$-5.48M	$-7.67M	$-4.12M	$-27.38M	$-2.45M	$-2.67M	$-2.31M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 7 years · 27 quarters

Vera Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare VERA with peers